Literature DB >> 9454744

The cytoplasmic domain of stem cell antigen CD34 is essential for cytoadhesion signaling but not sufficient for proliferation signaling.

M C Hu1, S L Chien.   

Abstract

CD34 is widely used as a marker in the identification and purification of human hematopoietic stem and progenitor cells; however, its function within hematopoiesis is largely unknown. We have investigated the contribution of cytoplasmic domain of CD34 in cytoadhesion signaling and proliferation signaling in hematopoietic cells. Engagement of particular determinants of CD34 by monoclonal antibodies leads to homotypic adhesiveness of the full-length CD34-transfected BaF3 cells. However, this homotypic adhesiveness is abrogated in BaF3 cells transfected with the truncated CD34 lacking the cytoplasmic domain. Cytoadhesion signaling through the cytoplasmic domain of CD34 cannot be restored through that of erythropoietin receptor (EPOR) or granulocyte colony-stimulating factor receptor (G-CSFR), suggesting that the cytoplasmic domain of CD34 is required for its signal transduction of cellular adhesion. In constrast, we show that replacing the cytoplasmic domain of EPOR or G-CSFR with that of CD34 abolished growth signal transduction in response to EPO or G-CSF in the chimeric receptor-transfected BaF3, 32D, and FDCP1 cells, whereas the wild-type EPOR- or G-CSFR-transfected cells responded to EPO or G-CSF growth signaling well. These results suggest that the cytoplasmic portion of CD34 may not contain the elements necessary to transduce a proliferative signal in hematopoietic cells. Thus, the function of CD34 in hematopoiesis is primarily on hematopoietic cell adhesion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454744

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

Authors:  Alexander R Mackie; Douglas W Losordo
Journal:  Tex Heart Inst J       Date:  2011

Review 2.  Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis.

Authors:  Sebastian George Barton Furness; Kelly McNagny
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Immunoblot analysis of CD34 expression in histologically diverse neoplasms.

Authors:  Y Natkunam; R V Rouse; S Zhu; C Fisher; M van De Rijn
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

4.  Not just a marker: CD34 on human hematopoietic stem/progenitor cells dominates vascular selectin binding along with CD44.

Authors:  Dina B AbuSamra; Fajr A Aleisa; Asma S Al-Amoodi; Heba M Jalal Ahmed; Chee Jia Chin; Ayman F Abuelela; Ptissam Bergam; Rachid Sougrat; Jasmeen S Merzaban
Journal:  Blood Adv       Date:  2017-12-26

5.  Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal.

Authors:  T L Robinson; K Sircar; B R Hewlett; K Chorneyko; R H Riddell; J D Huizinga
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

6.  Glomerular CD34 expression in short- and long-term diabetes.

Authors:  Luz Marina Acevedo; Irene Londono; Malika Oubaha; Lucian Ghitescu; Moise Bendayan
Journal:  J Histochem Cytochem       Date:  2008-03-03       Impact factor: 2.479

7.  Impact of crosslinking/riboflavin-UVA-photodynamic inactivation on viability, apoptosis and activation of human keratocytes in vitro.

Authors:  Tanja Stachon; Jiong Wang; Xufei Song; Achim Langenbucher; Berthold Seitz; Nóra Szentmáry
Journal:  J Biomed Res       Date:  2015-05-01

8.  CD34 expression modulates tube-forming capacity and barrier properties of peripheral blood-derived endothelial colony-forming cells (ECFCs).

Authors:  Dimitar Tasev; Lara S F Konijnenberg; Joana Amado-Azevedo; Michiel H van Wijhe; Pieter Koolwijk; Victor W M van Hinsbergh
Journal:  Angiogenesis       Date:  2016-04-04       Impact factor: 9.596

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.